Biocryst Pharmaceuticals (BCRX) Debt Ratio (2011 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Debt Ratio came in at 0.94 in Q1 2026, up 28.55% YoY from 0.73 in Q1 2025, and up 1152.12% on a QoQ basis from 0.07 in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Debt Ratio (2011 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 16 years of Debt Ratio data on file, last reported at 0.94 in Q1 2026.
- Quarterly Debt Ratio rose 28.55% year-over-year to 0.94 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.94 (up 28.55% YoY) and the FY2025 annual result came in at 0.07, down 89.45% from the prior year.
- Debt Ratio rose to 0.94 in Q1 2026, from 0.07 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.94 in Q1 2026 to a low of 0.07 in Q4 2025.
- A 5-year average of 0.55 and a median of 0.57 in 2023 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2023 — Debt Ratio jumped 95.46% — and 2025, when it sank 89.45%.
- Tracing BCRX's Debt Ratio over 5 years: stood at 0.42 in 2022, then jumped by 50.11% to 0.63 in 2023, then climbed by 12.1% to 0.71 in 2024, then slumped by 89.45% to 0.07 in 2025, then soared by 1152.12% to 0.94 in 2026.
- The last three Debt Ratio figures came in at 0.94 (Q1 2026), 0.07 (Q4 2025), and 0.52 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -0.13 |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 0.42 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 0.32 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.38 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.29 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 0.12 |
| 10 | Biocryst Pharmaceuticals | 2.45 Bn | 2.10 Bn | 214.41 Mn | 0.79 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.79 |
| Mar 31, 2026 | 0.94 |
| Dec 31, 2025 | 0.07 |
| Sep 30, 2025 | 0.52 |
| Jun 30, 2025 | 0.61 |
| Mar 31, 2025 | 0.73 |
| Dec 31, 2024 | 0.71 |
| Sep 30, 2024 | 0.71 |
| Jun 30, 2024 | 0.73 |
| Mar 31, 2024 | 0.71 |
| Dec 31, 2023 | 0.63 |
| Sep 30, 2023 | 0.57 |
| Jun 30, 2023 | 0.55 |
| Mar 31, 2023 | 0.46 |
| Dec 31, 2022 | 0.42 |
| Sep 30, 2022 | 0.40 |
| Jun 30, 2022 | 0.28 |
| Mar 31, 2022 | 0.27 |
| Dec 31, 2021 | 0.51 |
| Sep 30, 2021 | 0.50 |